ScreenerHero

XOMAPXOMA Corporation

NAS · US · Healthcare · Biotechnology · xoma.com
24.98USD0.00%Mkt Cap: —P/E: 24.95

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty paymen…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap—
Enterprise Value371.98M $
Revenue (TTM)48.55M $
Gross Profit48.09M $
Net Income (TTM)31.71M $
Revenue/Share4.025 USD
Last Price24.98 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees14
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)24.95
P/E (Forward)—
PEG—
EV/EBITDA44.84
EV/Revenue7.66
P/S—
P/B3.20
EPS (TTM)1.00
EPS (Forward)—
52W Range
24.931% of range30.00
52W High30.00 USD
52W Low24.93 USD
Profitability
Gross Margin99.04%
Oper. Margin-3.90%
EBITDA Margin17.08%
Profit Margin271.97%
ROE37.78%
ROA11.63%
Growth
Revenue Growth-22.60%
Earnings Growth207.90%
Cash Flow & Leverage
Operating CF2.87M $
CapEx (TTM)20.73M $
FCF Margin-26.92%
FCF Yield—
Net Debt38.64M $
Net Debt/EBITDA4.66
Balance Sheet
Debt/Equity1.57
Current Ratio3.59
Quick Ratio3.31
Book Value/Sh7.794 USD
Cash/Share6.865 USD
Dividends
Fwd Div Rate2.160 USD
Trail. Div Rate0.0000 USD
Div. Yield8.63%
5Y Avg Yield8.23%
Payout Ratio—
Ex-Div DateJul 2, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float4.80M
Insiders0.00%
Institutions1.02%
Short Interest
Short Ratio0.1d
Shares Short556
Short (prev mo.)84
Technical
SMA 5025.31 (-1.3%)
SMA 20026.00 (-3.9%)
Beta0.86
S&P 52W Chg18.16%
Avg Vol (30d)2.07K
Avg Vol (10d)915
Technical Indicators
RSI (14)29.3
MACD-0.1299
MACD Signal-0.1211
MACD Hist.-0.0089
BB Upper25.68 USD
BB Middle25.18 USD
BB Lower24.67 USD
BB Width4.03%
ATR (14)0.0514 USD
Vol Ratio (20d)0.00x